The IATA Biomed Israel conference is planned in Tel Aviv for early next month. The organizing committee is expecting approximately 6,000 visitors, over 1,000 of whom are expected from outside Israel. The conference focuses on life science and device innovations of different stages, from Teva Pharmaceuticals (Petach Tikva), to technology startups with a name, limited IP, and no full-time employees. The environment is ripe for generating new ideas, and especially for local and international networking. Last year's 3,500 one-on-one networking meetings will likely be equaled in number this year, and based on the number of returning guests, there seems to be great promise in the Promised Land.